We are live on ! Find out more
BSX icon

Boston Scientific

455 hedge funds and large institutions have $16.5B invested in Boston Scientific in 2014 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 151 increasing their positions, 163 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 42

11% more capital invested

Capital invested by funds: $14.8B → $16.5B (+$1.64B)

5% more funds holding

Funds holding: 435455 (+20)

0.31% more ownership

Funds ownership: 90.16%90.48% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

7% less repeat investments, than reductions

Existing positions increased: 151 | Existing positions reduced: 163

52% less call options, than puts

Call options by funds: $49.1M | Put options by funds: $101M

Holders
455
Holders Change
+20
Holders Change %
+4.6%
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
69
Increased
151
Reduced
163
Closed
42
Calls
$49.1M
Puts
$101M
Net Calls
-$52.3M
Net Calls Change
-$90.9M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$27.4M -$28.9K -2,261 -0.1%
MFP
77
Michael F. Price
$26.2M -$256K -20,000 -1%
APG Asset Management
78
APG Asset Management
Netherlands
$25.8M -$685K -53,569 -3%
Principal Financial Group
79
Principal Financial Group
Iowa
$24.7M -$42.1M -3,296,013 -64%
Jacobs Levy Equity Management
80
Jacobs Levy Equity Management
New Jersey
$24.1M +$5.86M +458,560 +34%
Wells Fargo
81
Wells Fargo
California
$23.9M -$23M -1,802,107 -50%
RhumbLine Advisers
82
RhumbLine Advisers
Massachusetts
$23.4M -$230K -18,024 -1%
HSBC Holdings
83
HSBC Holdings
United Kingdom
$23.2M +$2.67M +209,230 +14%
MTB
84
Mizuho Trust & Banking
Japan
$22.9M +$1.02M +79,451 +5%
EAM
85
EverPoint Asset Management
Connecticut
$22.7M +$14.6M +1,140,000 +198%
GI
86
GAMCO Investors
Connecticut
$21.9M -$685K -53,590 -3%
ERM
87
Elm Ridge Management
New York
$21.2M -$9.65M -754,734 -32%
BJ
88
BlackRock Japan
Japan
$20.9M +$1.79M +140,407 +10%
CS
89
Candriam SCA
Luxembourg
$20.3M +$19.5M +1,528,825 New
GIA
90
Gateway Investment Advisers
Ohio
$20.1M -$1.23M -96,480 -6%
DCM
91
Decatur Capital Management
Georgia
$19.9M +$4.41M +344,580 +30%
CC
92
Chubb Corp
New Jersey
$19.9M
VAM
93
Visium Asset Management
New York
$19.2M +$18.5M +1,450,144 New
GF
94
Gabelli Funds
New York
$18.5M -$256K -20,000 -1%
Thrivent Financial for Lutherans
95
Thrivent Financial for Lutherans
Minnesota
$18.4M -$1.08M -84,750 -6%
Invesco
96
Invesco
Georgia
$18.2M -$236K -18,451 -1%
PMAM
97
Picton Mahoney Asset Management
Ontario, Canada
$17.6M +$16.9M +1,325,700 New
Asset Management One
98
Asset Management One
Japan
$17.5M +$14.7M +1,152,575 +693%
AAM
99
Aberdeen Asset Management
United Kingdom
$17.4M -$2.02M -158,130 -11%
Swiss National Bank
100
Swiss National Bank
Switzerland
$16.3M -$459K -35,900 -3%

BSX Hedge Fund Activity: Q4 2014 in Review

455 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2014, worth a combined $16.5B — up 11% from $14.8B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new BSX positions and 42 closed out — a net gain of 27 holders — while 151 added to existing stakes and 163 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $207M. The largest seller was Dodge & Cox, cutting an estimated $553M.

  • 455 institutional investors held Boston Scientific (BSX) as of Q4 2014, up from 435 in Q3 2014.
  • Funds reported $16.5B of Boston Scientific stock for Q4 2014, up 11% quarter-over-quarter.
  • 69 funds opened new Boston Scientific positions in Q4 2014 and 42 closed out, a net change of +27 holders.
  • The largest Boston Scientific buyer in Q4 2014 was Fidelity Investments, an estimated $207M added.
  • The largest Boston Scientific seller in Q4 2014 was Dodge & Cox, an estimated $553M sold.

Based on aggregated 13F filings for Q4 2014.